Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Spremljeno u:

Bibliografski detalji
Izdano u:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Glavni autor:	Niazi, Sarfaraz K
Izdano:	MDPI AG
Teme:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Online pristup:	Citation/Abstract Full Text + Graphics Full Text - PDF
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Budi prvi tko komentira!